1. A combined single high-dose rate brachytherapy boost with hypofractionated external beam radiotherapy results in a high rate of biochemical disease free survival in localised intermediate and high risk prostate cancer patients. Issue 2 (November 2016) Authors: Joseph, Nuradh; Taylor, Cathy; O'Hara, Catherine; Choudhury, Ananya; Elliott, Tony; Logue, John; Wylie, James Journal: Radiotherapy and oncology Issue: Volume 121:Issue 2(2016:Nov.) Page Start: 299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase II trial of cabazitaxel as second line chemotherapy in relapsed locally advanced and/or metastatic carcinoma of the penis. Issue 10 (October 2019) Authors: Challapalli, Amarnath; Pearson, Sylvia; Mitra, Anita V.; Coe, Marc; Thomson, Alastair; Elliott, Tony; Kirkbride, Peter; Pickering, Lisa; Kirk, Hannah; Foulstone, Emily; Evans, Heidi; Bravo, Alicia; Bahl, Amit K. Journal: Journal of international medical research Issue: Volume 47:Issue 10(2019) Page Start: 4664 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A randomised Phase II trial of carboplatin and gemcitabine ± vandetanib in first‐line treatment of patients with advanced urothelial cell cancer not suitable to receive cisplatin. (19th May 2020) Authors: Jones, Robert; Crabb, Simon; Chester, John; Elliott, Tony; Huddart, Robert; Birtle, Alison; Evans, Linda; Lester, Jason; Jagdev, Satinder; Casbard, Angela; Huang, Chao; Madden, Tracie‐Ann; Griffiths, Gareth Journal: BJU international Issue: Volume 126:Number 2(2020) Page Start: 292 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial. Issue 10024 (19th March 2016) Authors: James, Nicholas D; Sydes, Matthew R; Clarke, Noel W; Mason, Malcolm D; Dearnaley, David P; Spears, Melissa R; Ritchie, Alastair W S; Parker, Christopher C; Russell, J Martin; Attard, Gerhardt; de Bono, Johann; Cross, William; Jones, Rob J; Thalmann, George; Amos, Claire; Matheson, David; Millman,... Journal: Lancet Issue: Volume 387:Issue 10024(2016) Page Start: 1163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Advanced prostate cancer: advancing patient care. Issue 1 (January 2014) Authors: Payne, Heather A.; Parker, Chris; Clarke, Noel; Farnham, Chris; Shah, Nimish; Mazhar, Danish; Huddart, Robert; Green, James; Elliott, Tony Journal: Trends in urology & men's health Issue: Volume 5:Issue 1(2014) Page Start: 40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity. (20th June 2012) Authors: Thomson, David; Merrick, Sophie; Swindell, Ric; Coote, Joanna; Kelly, Kay; Stratford, Julie; Wylie, James; Cowan, Richard; Elliott, Tony; Logue, John; Choudhury, Ananya; Livsey, Jacqueline Other Names: Ben-Yosef Rami Academic Editor. Journal: Prostate cancer Issue: Volume 2012(2012) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Making sense of problems in primary headship. (2019) Authors: Dunning, Gerald; Elliott, Tony Record Type: Book Extent: 1 online resource View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial. Issue 1 (January 2020) Authors: Mateo, Joaquin; Porta, Nuria; Bianchini, Diletta; McGovern, Ursula; Elliott, Tony; Jones, Robert; Syndikus, Isabel; Ralph, Christy; Jain, Suneil; Varughese, Mohini; Parikh, Omi; Crabb, Simon; Robinson, Angus; McLaren, Duncan; Birtle, Alison; Tanguay, Jacob; Miranda, Susana; Figueiredo, Ines; Seed... Journal: Lancet oncology Issue: Volume 21:Issue 1(2020) Page Start: 162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Orteronel Switch Maintenance Therapy in Metastatic Castration Resistant Prostate Cancer After First‐Line Docetaxel: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Trial (SAKK 08/11). Issue 16 (25th July 2016) Authors: Cathomas, Richard; Crabb, Simon J.; Mark, Michael; Winterhalder, Ralph; Rothermundt, Christian; Elliott, Tony; von Burg, Philippe; Kenner, Heike; Hayoz, Stefanie; Vilei, Simona Berardi; Rauch, Daniel; Roggero, Enrico; Mohaupt, Markus G.; Bernhard, Jürg; Manetsch, Gabriela; Gillessen, Silke Journal: Prostate Issue: Volume 76:Issue 16(2016) Page Start: 1519 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Outcome and patient-reported toxicity in localised prostate cancer treated with dose-escalated hypofractionated intensity-modulated radiotherapy. Issue 4 (23rd April 2013) Authors: Thomson, David; Merrick, Sophie; Swindell, Ric; Wylie, James; Cowan, Richard; Elliott, Tony; Logue, John; Livsey, Jacqueline; Choudhury, Ananya Journal: Journal of radiotherapy in practice Issue: Volume 12:Issue 4(2013) Page Start: 326 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗